27 completed, 11 unknown, 3 not yet recruiting, 3 recruiting. 15 Not applicable, 10 Phase 4, 2 Phase 1, 2 Phase 2.
Follow Anticoagulation: new trials by email Literature Review of Anticoagulation trials Research Report on Anticoagulation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Anticoagulation for Central Venous Line Insertion in Critically Ill Children Enoxaparin - Prophylactic, Anticoagulation | Not applicable | Recruiting | Menoufia University | 40 | 2026-08-01 | 2026-10-07 |
| Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention) Administration of heparin after sheath insertion, Administration of heparin prior to sheath insertion - Coronary Angiography, Percutaneous Coronary Intervention | Not applicable | Recruiting | University Hospital, Strasbourg, France | 550 | 2025-06-05 | 2026-05-26 |
| Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study POCT test - Anticoagulation | Phase 4 | Not yet recruiting | RenJi Hospital | 416 | 2025-01-01 | 2024-10-16 |
| Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves Rivaroxaban - Anticoagulation | Phase 4 | Not yet recruiting | RenJi Hospital | 250 | 2024-08-01 | 2024-06-28 |
| Preliminary Exploration of Thromboelastography in the Monitoring of Anticoagulation in Maintenance Hemodialysis Patients Thromboelastography, Hemodialysis | Unknown | RenJi Hospital | 200 | 2024-01-29 | 2024-02-22 | |
| Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis Extended anticoagulation - Embolism and Thrombosis, Anticoagulation | Not applicable | Not yet recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 220 | 2024-01-01 | 2024-01-18 |
| Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy Warfarin, DAPT, CE+CABG - Anticoagulation, Coronary Endarterectomy | Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | 202 | 2023-04-11 | 2025-11-18 |
| Anticoagulation Adherence Measurement Strategies Anticoagulation | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 30 | 2023-01-09 | 2025-08-19 | |
| Efficacy and Safety of Nafamostat Mesylate for VV-ECMO Anticoagulation Nafamostat Mesylate, Unfractionated Heparin - Critical Illness, Anticoagulation | Phase 2 | Unknown | Xiaobo Yang, MD | 40 | 2022-12-20 | 2023-02-15 |
| AntiCoagulation Tracking InterVention and Evaluation Panel Management for Anticoagulation Therapy, Usual Care - Anticoagulation, Atrial Fibrillation | Not applicable | Withdrawn | University of California, San Francisco | 2022-10-01 | 2022-08-04 | |
| Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions early anticoagulation, late anticoagulation - Mitral Regurgitation, Atrial Fibrillation | Phase 4 | Enrolling by invitation | National Institute of Cardiology, Warsaw, Poland | 410 | 2022-03-13 | 2026-09-17 |
| Rural Hospital-Level Care at Home for Acutely Ill Adults Home Hospital care, Traditional Hospital care - Infections, Heart Failure | Not applicable | Completed | Brigham and Women's Hospital | 160 | 2022-02-16 | 2025-11-12 |
| Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation unfractionated heparin, Sodium Citrate - Apheresis, Anticoagulation | Phase 4 | Completed | University Medical Centre Ljubljana | 15 | 2022-01-21 | 2023-11-29 |
| ROTEM-based Optimization of Anticoagulation Regimens in Lung Transplantation Anticoagulation, Lung Transplantation | Completed | University Hospital, Motol | 65 | 2022-01-01 | 2025-01-16 | |
| Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels Estimated anticoagulant level (conversion factor x anti-Xa activity) - Anticoagulation, Venous Thromboembolism | Unknown | Nantes University Hospital | 2100 | 2021-04-01 | 2024-05-07 | |
| Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition Apixaban single dose, Apixaban steady-state - Short Bowel Syndrome, Anticoagulation | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 70 | 2020-12-20 | 2026-10-15 |
| Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane unfractionated heparin, 8% trisodium citrate - End Stage Renal Disease, Haemodialysis | Not applicable | Unknown | Marija Malgaj Vrečko | 32 | 2020-09-15 | 2022-06-07 |
| Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation CVVH with Phoxilium® in the first 48h after randomization, CVVH with Biphozyl® in the first 48h after randomization, CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®) - Critically Ill, Acute Kidney Injury | Phase 2 | Completed | Medical University Innsbruck | 88 | 2020-08-01 | 2024-03-13 |
| Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK Non-interventional - COVID, Thrombosis | Unknown | Imperial College London | 5000 | 2020-05-25 | 2020-07-31 | |
| Impact of Clinical Pharmacist Interventions in Vitamin K Antagonists Management at One Teaching Hospital in Vietnam Patient education and compliance - Anticoagulation | Not applicable | Unknown | University of Medicine and Pharmacy at Ho Chi Minh City | 800 | 2019-08-01 | 2019-06-26 |
Showing 20 of 48. Sign in to see all of them.
Atrial Fibrillation (3) · Critical Illness (2) · Hemorrhage (2) · Acute Kidney Injury (1) · Arterial Occlusive Diseases (1) · Asthma (1) · Atrial Flutter (1) · Diabetes Mellitus (1) · Embolism (1) · Embolism and Thrombosis (1) · Heart Failure (1) · Hypertensive Crisis (1) · Infections (1) · Kidney Failure, Chronic (1) · Liver Cirrhosis (1)
Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Cardiovascular Diseases (8) · Vascular Diseases (7) · Disease Attributes (4) · Embolism and Thrombosis (4) · Heart Diseases (4) · Arrhythmias, Cardiac (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Renal Insufficiency (3) · Urogenital Diseases (3) · Urologic Diseases (3)
apixaban (6) · Warfarin (5) · Heparin (4) · Rivaroxaban (3) · Dabigatran (2) · Standard of Care (2) · Compliance (1) · Dalteparin (1) · Enoxaparin (1) · Home Care Services, Hospital-Based (1) · Nadroparin (1) · Patient Education as Topic (1) · Saline Solution (1) · Sodium Citrate (1) · acarboxyprothrombin (1)
Bristol-Myers Squibb (8) · RenJi Hospital (4) · Bayer (2) · Brigham and Women's Hospital (2) · University Medical Centre Ljubljana (2) · University of Alberta (2) · Aalborg University Hospital (1) · Abbott Medical Devices (1) · Air Force Military Medical University, China (1) · Children's Hospital Medical Center, Cincinnati (1) · China National Center for Cardiovascular Diseases (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Goethe University (1) · Guangdong Provincial People's Hospital (1) · Imperial College London (1)
United States (7) · France (6) · China (5) · Canada (3) · Germany (3) · Slovenia (3) · Austria (2) · Czechia (2) · United Kingdom (2) · Belgium (1) · Brazil (1) · Denmark (1) · Egypt (1) · Finland (1) · India (1)
Afshan B Hameed, MD (1) · Bruce Ritchie, MD, FRCPC (1) · Carla Staresinic, PharmD (1) · Christine Sorkness, Pharm D (1) · David Farrar, PhD (1) · Dr Deepa Jayakody Arachchillage, FRCPath, MD (1) · Guohong Han, PhD,MD (1) · Hani Hamed Saad, MD, pediatrics (1) · Jean M Connors, MD (1) · Juhani Airaksinen, Professor (1) · Liming Yao, M.D. (1) · Lori Luchtman-Jones, MD (1)
PMID 29029233, PMID 30285032, PMID 30636632, PMID 31752504, PMID 32273033, PMID 36303108, PMID 38189593, PMID 38401649, PMID 38521486, PMID 39900192, PMID 40759107, PMID 41213699, PMID 41247497, PMID 41324962, PMID 42555132